ArticleJournal of cancer research and clinical oncology2018

Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.

Hans D Menssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.